Kazuki Hatcho
Overview
Explore the profile of Kazuki Hatcho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alkhouri N, Johnson C, Adams L, Kitajima S, Tsuruno C, Colpitts T, et al.
PLoS One
. 2018 Oct;
13(10):e0205541.
PMID: 30286196
[This corrects the article DOI: 10.1371/journal.pone.0202226.].
2.
Alkhouri N, Johnson C, Adams L, Kitajima S, Tsuruno C, Colpitts T, et al.
PLoS One
. 2018 Aug;
13(8):e0202226.
PMID: 30161179
Objective: The race for finding effective treatments for nonalcoholic fatty liver disease (NAFLD) has been slowed down by the high screen-failure rate for including patients in trials due to the...
3.
Nagao T, Hatcho K, Doi N, Fujiwara S, Adachi A, Nomaguchi M
J Med Invest
. 2009 Mar;
56(1-2):21-5.
PMID: 19262010
We previously generated a prototype monkey-tropic human immunodeficiency virus type 1 (HIV-1) designated NL-DT5R. This viral clone has a small region of simian immunodeficiency virus (SIV) within Gag capsid (CA)...
4.
Kamada K, Yamashita T, Hatcho K, Adachi A, Nomaguchi M
Microbes Infect
. 2008 Dec;
11(2):164-71.
PMID: 19056509
We have recently generated a monkey cell-tropic virus termed NL-DT5R from an HIV-1 NL4-3 clone and demonstrated that both cyclophilin A (CypA)-binding loop in Gag-capsid (CA) and Vif are responsible...
5.
Hatcho K, Kamada K, Yamashita T, Adachi A, Nomaguchi M
Microbes Infect
. 2008 Jul;
10(10-11):1218-22.
PMID: 18617010
To obtain monkey-tropic viruses that are more closely related to HIV-1 than the original NL-DT5/NL-DT5R clones, we constructed six vif-chimeric and two site-specific vif-mutant viruses, and examined their growth ability....
6.
Yamashita T, Kamada K, Hatcho K, Adachi A, Nomaguchi M
Microbes Infect
. 2008 Jul;
10(10-11):1142-9.
PMID: 18603011
To define a region(s) in human immunodeficiency virus type 1 (HIV-1) Vif that involves binding to its target APOBEC3G (A3G), we have generated a series of site-specific proviral vif mutants....
7.
Adachi A, Kamada K, Hatcho K, Yamashita T, Uchiyama T, Nomaguchi M
Tanpakushitsu Kakusan Koso
. 2007 Sep;
52(10 Suppl):1261-7.
PMID: 17824250
No abstract available.
8.
Kamada K, Igarashi T, Martin M, Khamsri B, Hatcho K, Yamashita T, et al.
Proc Natl Acad Sci U S A
. 2006 Oct;
103(45):16959-64.
PMID: 17065315
The narrow host range of human immunodeficiency virus type 1 (HIV-1) is caused in part by innate cellular factors such as apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) and TRIM5alpha,...